These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Characteristics of patients with the highest plasma catecholamine metabolite levels. Bowers MB, Swigar ME, Hoffman FJ, Goicoechea N. Am J Psychiatry; 1988 Feb 01; 145(2):246-8. PubMed ID: 3422545 [Abstract] [Full Text] [Related]
5. Cerebrospinal fluid homovanillic acid is correlated to psychotic features in neurological patients with delirium. Ramirez-Bermudez J, Ruiz-Chow A, Perez-Neri I, Soto-Hernandez JL, Flores-Hernandez R, Nente F, Montes S, Rios C. Gen Hosp Psychiatry; 2008 Feb 01; 30(4):337-43. PubMed ID: 18585537 [Abstract] [Full Text] [Related]
9. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs. Sedvall G. Prog Biochem Pharmacol; 1980 Mar 15; 16():133-40. PubMed ID: 6160594 [Abstract] [Full Text] [Related]
10. Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: a within-subject comparison with haloperidol. Brown AS, Gewirtz G, Harkavy-Friedman J, Cooper T, Brébion G, Amador XF, Malaspina D, Gorman JM. Neuropsychopharmacology; 1997 Nov 15; 17(5):317-25. PubMed ID: 9348547 [Abstract] [Full Text] [Related]
11. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF. Nikisch G, Baumann P, Wiedemann G, Kiessling B, Weisser H, Hertel A, Yoshitake T, Kehr J, Mathé AA. J Clin Psychopharmacol; 2010 Oct 15; 30(5):496-503. PubMed ID: 20814316 [Abstract] [Full Text] [Related]
13. Risperidone in the treatment of psychotic depression. Goto M, Yoshimura R, Kakihara S, Shinkai K, Yamada Y, Kaji K, Ueda N, Nakamura J. Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun 15; 30(4):701-7. PubMed ID: 16580110 [Abstract] [Full Text] [Related]
14. Studies of catecholamine metabolism in schizophrenia/psychosis--II. Maas JW, Contreras SA, Miller AL, Berman N, Bowden CL, Javors MA, Seleshi E, Weintraub SE. Neuropsychopharmacology; 1993 Feb 15; 8(2):111-6. PubMed ID: 8471122 [Abstract] [Full Text] [Related]
15. CSF levels of HVA and 5-HIAA in drug-free schizophrenic patients and healthy controls: a prospective study focused on their predictive value for outcome in schizophrenia. Wieselgren IM, Lindström LH. Psychiatry Res; 1998 Nov 16; 81(2):101-10. PubMed ID: 9858027 [Abstract] [Full Text] [Related]
16. Lithium in combination with perphenazine: effect on plasma monoamine metabolites. Bowers MB, Mazure CM, Nelson JC, Jatlow PI. Biol Psychiatry; 1992 Dec 15; 32(12):1102-7. PubMed ID: 1477190 [Abstract] [Full Text] [Related]
19. Relationship between 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in saliva and plasma of healthy volunteers. Yang RK, Yehuda R, Holland DD, Knott PJ. Biol Psychiatry; 1997 Nov 01; 42(9):821-6. PubMed ID: 9347131 [Abstract] [Full Text] [Related]